For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The metronidazole industry concentration is not high. In the world wide, China has a long history and unshakable status in this industry and the giant manufactures mainly focus in Hubei province,such as Hongyuan and Yinhe. With the future capacity growth, China metronidazole production is in the rising trend.
With the raw material changes, the global metronidazole average price is in the decline trend. The global metronidazole production shows an increasing trend.
All manufactures in the world are committed to the improvement of the metronidazole industry. In two years, with the development of the metronidazole industry, waste water has become a serious source of pollution. Therefore some companies mainly pay attention to improving technology process, in order to form circular production and reduce costs.
We tend to believe this industry now is close to mature, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies.
The worldwide market for Metronidazole is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Hongyuan Pharmaceutical
- Yinhe Aarti Pharmaceutical
- Saikang Pharmaceutical
- Zhongan Pharmaceutical
- Wuyao Pharmaceutical
- Yichang Changjiang Pharmaceutical
- Tongji Pharmaceutical
- Hongda Pharmaceutical
- Topsun Pharmaceutical
- Unichem Laboratories
- CordenPharma Farchemia
- API Polpharma
- Manav Drugs
- Aarey Drugs & Pharmaceuticals
- Aarti Drugs
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Glyoxal Process
- Ethidene Diamine Process
Market Segment by Applications, can be divided into
- Metronidazole Tablets
- Metronidazole Capsule
- Metronidazole Injection
There are 15 Chapters to deeply display the global Metronidazole market.
Chapter 1, to describe Metronidazole Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Metronidazole, with sales, revenue, and price of Metronidazole, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Metronidazole, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Metronidazole market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Metronidazole sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source